Does the reason for discontinuation of a first TNF inhibitor influence the effectiveness of a second TNF inhibitor in axial spondyloarthritis? Results from the Swiss Clinical Quality Management Cohort.
about
Impact of obesity on the response to tumor necrosis factor inhibitors in axial spondyloarthritis.An update on the use of tumor necrosis factor alpha inhibitors in the treatment of ankylosing spondylitis.Switching biological disease-modifying antirheumatic drugs in patients with axial spondyloarthritis: results from a systematic literature reviewTreatment patterns of biologics in US patients with ankylosing spondylitis: descriptive analyses from a claims database.
P2860
Does the reason for discontinuation of a first TNF inhibitor influence the effectiveness of a second TNF inhibitor in axial spondyloarthritis? Results from the Swiss Clinical Quality Management Cohort.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Does the reason for discontinu ...... cal Quality Management Cohort.
@ast
Does the reason for discontinu ...... cal Quality Management Cohort.
@en
type
label
Does the reason for discontinu ...... cal Quality Management Cohort.
@ast
Does the reason for discontinu ...... cal Quality Management Cohort.
@en
prefLabel
Does the reason for discontinu ...... cal Quality Management Cohort.
@ast
Does the reason for discontinu ...... cal Quality Management Cohort.
@en
P2093
P2860
P1476
Does the reason for discontinu ...... ical Quality Management Cohort
@en
P2093
Almut Scherer
Beate Steininger
Giorgio Tamborrini
Jürg Bernhard
Pascale Exer
Rheumatologists of Swiss Clinical Quality Management Program for Axial Spondyloarthritis
Rudolf O Kissling
Ulrich Weber
P2860
P2888
P356
10.1186/S13075-016-0969-2
P577
2016-03-22T00:00:00Z
P5875
P6179
1042895881